In this month's Daily Journal column, Ariel Rogers look at two industry-specific cases: Quishenberry v. UnitedHealthcare, Inc., which evaluates preemption under Medicare Part C (and preemption more broadly); and HNHPC v. Department of Cannabis Control. Companies in the healthcare and cannabis industries.
Related Content
- AlertOctober 17, 2025
Watch Out Section 101, the USPTO Has a New Sheriff in Town
- AlertJune 27, 2025
Northern District of California Judge Rules That Meta’s Training of AI Models Is Fair Use
- AlertJune 25, 2025
District Court Issues AI Fair Use Decision: Using Copyrighted Works to Train AI Models Is Fair Use, but Using Pirated Copies to Build a Central Library Is Not
- AlertMay 22, 2025
House Passes 10-Year Federal Moratorium on State AI Regulation: Key Implications for Businesses
- AlertApril 2, 2025
The Court of Appeals for the Federal Circuit’s In Re Riggs Decision: 35 USC 102(e) Prior Art Requires Written Description Support in Provisional Application for Disclosure Relied On to Reject Claims
- AlertMarch 21, 2025
The Court of Appeals for the Federal Circuit’s In Re Xencor Decision: Jepson Claims Require Written Description for Their Preambles
- AlertNovember 21, 2024
Second Circuit Sees Eye to Eye With Warby Parker in Trademark Google Ads Dispute
- InsightNovember 1, 2024
Four Steps to Maximize the Value of AI Innovation in Medtech
- Press ReleaseNovember 10, 2025
Goodwin Secures Unanimous Defense Verdict for Central Coast Agriculture in Trademark Trial
- EventsOctober 30, 2025
An Evening with Goodwin: AI Leaders Dinner
- Awards and RankingsOctober 29, 2025
IAM Global Leaders 2026 Recognizes Six Goodwin Partners
- Awards and RankingsOctober 29, 2025
Benchmark Litigation US 2026 Recognize Partners and Practices Nationwide
- Awards and RankingsOctober 16, 2025
Chambers UK 2026 Highly Ranks Goodwin UK’s Platform
- Press ReleaseOctober 8, 2025
Goodwin Guides Pharmakon Advisors on Refinancing Debt with Valneva
- Awards and RankingsOctober 1, 2025
The Legal 500 UK 2026 Highly Ranks Goodwin’s UK Platform
- Press ReleaseSeptember 8, 2025
Goodwin Advises Pharmakon Advisors on $125 Million Credit Facility for Precigen